Total Positions
185
Quarter
2025 Q4
Top Holding
RVMD (7.6%)
Top 10 Concentration
49.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 185
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 7.56% | 5.41% |
#1
2
Prev: #3
|
3.1 | -568,119 | -10.2% |
P
S
|
5,005,719 | $398,705,518 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 7.36% | 8.37% |
#2
Prev: #2
|
3.0 | -84,474 | -15.5% |
P
S
|
461,854 | $388,396,121 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 7.20% | 8.49% |
#3
2
Prev: #1
|
2.9 | -1,442,252 | -23.1% |
P
S
|
4,802,199 | $379,901,963 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 5.85% | 4.12% |
#4
2
Prev: #6
|
4.4 | 175,315 | 34.7% |
P
S
|
681,120 | $308,792,563 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 4.58% | 5.14% |
#5
1
Prev: #4
|
1.8 | -59,801 | -3.4% |
P
S
|
1,703,304 | $241,579,606 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 3.60% | 1.95% |
#6
10
Prev: #16
|
3.5 | 478,107 | 22.2% |
P
S
|
2,630,969 | $189,771,794 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 3.46% | 3.24% |
#7
3
Prev: #10
|
1.4 | -26,598 | -7.6% |
P
S
|
322,028 | $182,383,778 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 3.39% | 2.51% |
#8
5
Prev: #13
|
3.4 | 812,055 | 25.0% |
P
S
|
4,056,592 | $178,692,878 | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 3.36% | 4.23% |
#9
4
Prev: #5
|
1.3 | -621 | -0.1% |
P
S
|
445,903 | $177,313,328 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABT
ABBOTT LABS
|
Healthcare | 3.13% | 4.11% |
#10
3
Prev: #7
|
1.3 | -161,648 | -10.9% |
P
S
|
1,316,915 | $164,996,280 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 2.90% | — |
#11
Prev: #—
|
3.2 | 10,735,195 | no change |
NEW
|
10,735,195 | $152,869,177 | 2019 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 2.82% | 3.37% |
#12
3
Prev: #9
|
1.1 | -100,243 | -6.0% |
P
S
|
1,559,606 | $148,708,432 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 2.57% | — |
#13
Prev: #—
|
3.0 | 4,358,527 | no change |
NEW
|
4,358,527 | $135,637,360 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYK
STRYKER CORPORA...
|
Healthcare | 2.40% | 3.46% |
#14
6
Prev: #8
|
1.0 | -90,519 | -20.1% |
P
S
|
360,577 | $126,731,999 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVL
NUVALENT INC
|
Healthcare | 1.98% | — |
#15
Prev: #—
|
2.8 | 1,037,468 | no change |
NEW
|
1,037,468 | $104,358,906 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 1.92% | 0.00% |
#16
116
Prev: #132
|
3.1 | 409,011 | 31174.6% |
P
S
|
410,323 | $101,161,033 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.86% | 1.91% |
#17
Prev: #17
|
2.7 | 60,000 | 1.7% |
P
S
|
3,617,669 | $98,255,890 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.84% | 2.11% |
#18
3
Prev: #15
|
0.7 | no change | no change |
P
S
|
2,796,803 | $97,077,032 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.69% | 1.45% |
#19
1
Prev: #20
|
2.7 | 146,463 | 16.3% |
P
S
|
1,043,096 | $88,923,935 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.63% | — |
#20
Prev: #—
|
2.7 | 1,698,152 | no change |
NEW
|
1,698,152 | $85,994,417 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 1.40% | 1.50% |
#21
3
Prev: #18
|
2.6 | 6,731 | 0.9% |
P
S
|
766,592 | $73,638,828 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 1.34% | 0.91% |
#22
7
Prev: #29
|
0.5 | -246 | -0.0% |
P
S
|
8,345,364 | $70,601,779 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IDXX
IDEXX LABS INC
|
Healthcare | 1.21% | 1.02% |
#23
3
Prev: #26
|
2.6 | 17,952 | 23.4% |
P
S
|
94,539 | $63,958,470 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.10% | 1.22% |
#24
2
Prev: #22
|
2.4 | 5,112 | 3.0% |
P
S
|
175,169 | $57,825,039 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Healthcare | 1.07% | 1.10% |
#25
1
Prev: #24
|
2.4 | 61,287 | 7.8% |
P
S
|
847,405 | $56,242,270 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.00% | 3.10% |
Sold All 😨
(Was: #11) |
0.3 | -3,714,736 | -100.0% |
CLOSED
|
— | $— | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 2.36% |
Sold All 😨
(Was: #14) |
0.3 | -2,389,314 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.00% | 0.87% |
Sold All 😨
(Was: #30) |
0.3 | -2,802,853 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HOLX
HOLOGIC INC
|
Healthcare | 0.00% | 0.35% |
Sold All 😨
(Was: #49) |
0.3 | -247,886 | -100.0% |
CLOSED
|
— | $— | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MGNX
MACROGENICS INC
|
Healthcare | 0.00% | 0.35% |
Sold All 😨
(Was: #50) |
0.3 | -9,919,992 | -100.0% |
CLOSED
|
— | $— | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BAX
BAXTER INTL INC
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #98) |
0.3 | -68,084 | -100.0% |
CLOSED
|
— | $— | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIDU
BAIDU INC
|
Communication Services | 0.00% | 0.01% |
Sold All 😨
(Was: #128) |
0.3 | -2,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.00% | 0.01% |
Sold All 😨
(Was: #130) |
0.3 | -35,052 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
MERUS N V
|
Healthcare | 0.00% | 0.00% |
Sold All 😨
(Was: #145) |
0.3 | -825 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 185 holdings